Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 8, 2002, Pages 730-738

  Sunaga, Noriaki ^a,b   Kohno, Takashi ^a   Yanagitani, Noriko ^a,b   Sugimura, Haruhiko ^c   Kunitoh, Hideo ^d   Tamura, Tomohide ^d   Takei, Yoshikazu ^b   Tsuchiya, Satoshi ^b   Saito, Ryusei ^b   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GENE PRODUCT; GLUTATHIONE TRANSFERASE T1; PROTEIN NQO1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; DNA REPAIR; FEMALE; GENE ACTIVATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA DAMAGE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; QUINONE REDUCTASES; RISK FACTORS; SMOKING;

EID: 0036322465     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Smoking and lung cancer: Scientific challenges and opportunities
2. Cigarettes, sex, and lung adenocarcinoma
3. Cigarette smoking and changes in the histopathology of lung cancer
4. The increasing incidence of lung adenocarcinoma: Reality or artifact? A review of the epidemiology of lung adenocarcinoma
5. Drug metabolism polymorphisms as modulators of cancer susceptibility
6. Chapter 22. Interactions between detoxifying enzyme polymorphisms and susceptibility to cancer
7. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
8. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility
9. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes
10. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure
11. Association of Ile462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: Further evidence from a case-control study in Okinawa
12. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens
13. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population
14. Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons
15. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility
16. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis
17. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA
18. NAD(P)H:quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms
19. Mammalian class theta GST and differential susceptibility to carcinogens: A review
20. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism
21. Association of the NAD(P)H:quinone oxidoreductase 609C->T polymorphism with a decreased lung cancer risk
22. NAD(P)H:quinone oxidoreductase polymorphism and lung cancer in Taiwan
23. Dietary intake of isothiocyanates: Evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk
24. Glutathione S-transferase T1-null genotype interacts synergistically with heavy smoking on lung cancer risk
25. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: Differential susceptibility based on smoking behavior
26. Histological typing of lung and pleural tumors
27. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese
28. Multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms
29. Statistical methods in cancer research. Volume I. The analysis of case-control studies
30. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma
31. Carcinogenicities in mice and rats of IQ, MeIQ, and MeIQx
32. The biological significance of tobacco-specific N-nitrosamines: Smoking and adenocarcinoma of the lung
33. Tobacco smoke carcinogens and lung cancer
34. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking
35. Oxidative stress to DNA, protein, and antioxidant enzymes (superoxide dismutase and catalase) in rats treated with benzo(a)pyrene
36. Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population
37. hOGG1 exon7 polymorphism and gastric cancer in case-control studies of Japanese Brazilians and non-Japanese Brazilians
38. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors